Synercid (Quinupristin/Dalfopristin) (IV) - Antibiotics ...
839
Description

Synercid (Quinupristin/Dalfopristin) (IV) - Antibiotics Class Overview


Mechanism: “Streptogramins”– inhibits sequential steps in ribosomal synthesis
Spectrum: covers MRSA and VRE due to E.faecium.  Does not cover E.faecalis (has natural efflux pump).
Used for:Not much, as it is very poorly tolerated due to thrombophlebitis at IV siteà generally need central line.  Also severe myalgis/arthralgias and lots of drug-drug interactions (CYP450 inhibitor).  Poor choice for bacteremia/endocarditis due to static nature.


#Pharmacology #Antibiotics #Review #Overview #Synercid #Quinupristin #Dalfopristin
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Medical jobs
view all

0 Comments

Related content